198 related articles for article (PubMed ID: 20236069)
1. Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy.
Hirst D; Robson T
Curr Pharm Des; 2010; 16(4):411-20. PubMed ID: 20236069
[TBL] [Abstract][Full Text] [Related]
2. Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects.
Huang Z; Fu J; Zhang Y
J Med Chem; 2017 Sep; 60(18):7617-7635. PubMed ID: 28505442
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide: cancer target or anticancer agent?
Mocellin S
Curr Cancer Drug Targets; 2009 Mar; 9(2):214-36. PubMed ID: 19275761
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide and cancer therapy: the emperor has NO clothes.
Hickok JR; Thomas DD
Curr Pharm Des; 2010; 16(4):381-91. PubMed ID: 20236067
[TBL] [Abstract][Full Text] [Related]
5. [Nitric oxide and anti-protozoan chemotherapy].
Gradoni L; Ascenzi P
Parassitologia; 2004 Jun; 46(1-2):101-3. PubMed ID: 15305696
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological manipulation of nitric oxide levels in mouse follicle cultures demonstrates key role of extrafollicular control of ovulation.
Mitchell LM; Kennedy CR; Hartshorne GM
Hum Reprod; 2004 Aug; 19(8):1705-12. PubMed ID: 15229208
[TBL] [Abstract][Full Text] [Related]
7. The regulation of nitric oxide in tumor progression and therapy.
Hu Y; Xiang J; Su L; Tang X
J Int Med Res; 2020 Feb; 48(2):300060520905985. PubMed ID: 32090657
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide donors for prostate and bladder cancers: Current state and challenges.
Seabra AB; Durán N
Eur J Pharmacol; 2018 May; 826():158-168. PubMed ID: 29501865
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of nitric oxide: molecular mechanisms and therapeutic strategies.
Domenico R
Curr Pharm Des; 2004; 10(14):1667-76. PubMed ID: 15134564
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide donors: novel cancer therapeutics (review).
Huerta S; Chilka S; Bonavida B
Int J Oncol; 2008 Nov; 33(5):909-27. PubMed ID: 18949354
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of neuronal nitric oxide synthase by nitric oxide after oxygen-glucose deprivation in rat forebrain slices.
De Alba J; Cárdenas A; Moro MA; Leza JC; Lorenzo P; Boscá L; Lizasoain I
J Neurochem; 1999 Jan; 72(1):248-54. PubMed ID: 9886076
[TBL] [Abstract][Full Text] [Related]
12. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.
Yasuda H
Nitric Oxide; 2008 Sep; 19(2):205-16. PubMed ID: 18503779
[TBL] [Abstract][Full Text] [Related]
13. Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies.
Hajri A; Metzger E; Vallat F; Coffy S; Flatter E; Evrard S; Marescaux J; Aprahamian M
Br J Cancer; 1998 Oct; 78(7):841-9. PubMed ID: 9764573
[TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide in tumour progression: lessons from human tumours.
Thomsen LL; Miles DW
Cancer Metastasis Rev; 1998 Mar; 17(1):107-18. PubMed ID: 9544426
[TBL] [Abstract][Full Text] [Related]
15. Nitric Oxide. V. therapeutic potential of nitric oxide donors and inhibitors.
Muscará MN; Wallace JL
Am J Physiol; 1999 Jun; 276(6):G1313-6. PubMed ID: 10362633
[TBL] [Abstract][Full Text] [Related]
16. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors.
Mollace V; Muscoli C; Masini E; Cuzzocrea S; Salvemini D
Pharmacol Rev; 2005 Jun; 57(2):217-52. PubMed ID: 15914468
[TBL] [Abstract][Full Text] [Related]
17. Effects of a nitric oxide donor and nitric oxide synthase inhibitors on luteinizing hormone-induced ovulation in the ex-vivo perfused rat ovary.
Mitsube K; Mikuni M; Matousek M; Brännström M
Hum Reprod; 1999 Oct; 14(10):2537-43. PubMed ID: 10527984
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities.
Mocellin S; Bronte V; Nitti D
Med Res Rev; 2007 May; 27(3):317-52. PubMed ID: 16991100
[TBL] [Abstract][Full Text] [Related]
19. Nitrosative stress as a mediator of apoptosis: implications for cancer therapy.
Hirst DG; Robson T
Curr Pharm Des; 2010 Jan; 16(1):45-55. PubMed ID: 20214617
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide releasing nanomaterials for cancer treatment: current status and perspectives.
Seabra AB; de Lima R; Calderón M
Curr Top Med Chem; 2015; 15(4):298-308. PubMed ID: 25579351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
